Allan M. Fox
Chairman bij REGENXBIO INC.
Vermogen: 136 871 $ op 31-03-2024
Profiel
Allan M.
Fox was the founder of Dimension Therapeutics, Inc. (founded in 2013) where he held the title of Director.
He is also the founder of FoxKiser LLP (founded in 1986) where he currently holds the title of Managing Partner.
Mr. Fox's current job is Chairman at REGENXBIO, Inc. (since 2009).
His former jobs include being a Director at WindMIL Therapeutics, Inc. and a Principal at Kaye Scholer Fierman Hays & Handler.
Mr. Fox's education includes undergraduate and graduate degrees from Temple University (Pennsylvania) and a graduate degree from Yale Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REGENXBIO, INC.
0.01% | 02-06-2023 | 6 496 ( 0.01% ) | 136 871 $ | 31-03-2024 |
Actieve functies van Allan M. Fox
| Bedrijven | Functie | Begin |
|---|---|---|
| REGENXBIO INC. | Chairman | 01-07-2020 |
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Founder | 01-09-1986 |
Eerdere bekende functies van Allan M. Fox
| Bedrijven | Functie | Einde |
|---|---|---|
| Kaye Scholer Fierman Hays & Handler | Corporate Officer/Principal | - |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Director/Board Member | - |
| DIMENSION THERAPEUTICS INC | Founder | - |
Opleiding van Allan M. Fox
| Temple University (Pennsylvania) | Graduate Degree |
| Yale Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REGENXBIO INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Kaye Scholer Fierman Hays & Handler | Commercial Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services FOXKISER LLP engages in the provision of strategic advice and counseling services to pharmaceutical and biotechnology companies. Its project works fall into three general categories: advisory services; long-term partnerships; and new company formation. The company was founded by John Daniel Kiser and Allan M. Fox in September 1986 and is headquartered in Washington, DC. | Commercial Services |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Health Technology |
